Alprostadil is used to treat erectile dysfunction (impotence) and to help diagnose certain causes of this disorder.
Alprostadil is also used to improve blood flow in newborn babies with a certain genetic heart condition.
Alprostadil relaxes blood vessels and muscles in the penis. This increases blood flow into the penis, causing an erection.
The acquisition price is an upfront payment of $22m and a potential sales milestone payment of $1.5m based on future sales of MUSE.
The transaction is subject to standard closing requirements. The transaction is expected to close within 60 days.